Adaptive Biotechnologies Stock Forecast - 20 Period Moving Average
| ADPT Stock | USD 2.40 0.06 2.56% |
The 20 Period Moving Average forecasted value of Adaptive Biotechnologies Corp on the next trading day is expected to be 2.82 with a mean absolute deviation of 0.37 and the sum of the absolute errors of 15.32. Adaptive Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Adaptive Biotechnologies stock prices and determine the direction of Adaptive Biotechnologies Corp's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Adaptive Biotechnologies' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Adaptive Biotechnologies' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Adaptive Biotechnologies' systematic risk associated with finding meaningful patterns of Adaptive Biotechnologies fundamentals over time.
Check out Historical Fundamental Analysis of Adaptive Biotechnologies to cross-verify your projections. Adaptive |
Open Interest Against 2024-04-19 Adaptive Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Adaptive Biotechnologies' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Adaptive Biotechnologies' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Adaptive Biotechnologies stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Adaptive Biotechnologies' open interest, investors have to compare it to Adaptive Biotechnologies' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Adaptive Biotechnologies is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Adaptive. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Adaptive Biotechnologies cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Adaptive Biotechnologies' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Adaptive Biotechnologies' price structures and extracts relationships that further increase the generated results' accuracy.
A commonly used 20-period moving average forecast model for Adaptive Biotechnologies Corp is based on a synthetically constructed Adaptive Biotechnologiesdaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time. Adaptive Biotechnologies 20 Period Moving Average Price Forecast For the 20th of April
Given 90 days horizon, the 20 Period Moving Average forecasted value of Adaptive Biotechnologies Corp on the next trading day is expected to be 2.82 with a mean absolute deviation of 0.37, mean absolute percentage error of 0.17, and the sum of the absolute errors of 15.32.Please note that although there have been many attempts to predict Adaptive Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Adaptive Biotechnologies' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Adaptive Biotechnologies Stock Forecast Pattern
| Backtest Adaptive Biotechnologies | Adaptive Biotechnologies Price Prediction | Buy or Sell Advice |
Adaptive Biotechnologies Forecasted Value
In the context of forecasting Adaptive Biotechnologies' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Adaptive Biotechnologies' downside and upside margins for the forecasting period are 0.02 and 7.97, respectively. We have considered Adaptive Biotechnologies' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Adaptive Biotechnologies stock data series using in forecasting. Note that when a statistical model is used to represent Adaptive Biotechnologies stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 79.595 |
| Bias | Arithmetic mean of the errors | 0.2777 |
| MAD | Mean absolute deviation | 0.3737 |
| MAPE | Mean absolute percentage error | 0.122 |
| SAE | Sum of the absolute errors | 15.3235 |
Predictive Modules for Adaptive Biotechnologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Adaptive Biotechnologies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adaptive Biotechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Adaptive Biotechnologies
For every potential investor in Adaptive, whether a beginner or expert, Adaptive Biotechnologies' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Adaptive Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Adaptive. Basic forecasting techniques help filter out the noise by identifying Adaptive Biotechnologies' price trends.Adaptive Biotechnologies Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adaptive Biotechnologies stock to make a market-neutral strategy. Peer analysis of Adaptive Biotechnologies could also be used in its relative valuation, which is a method of valuing Adaptive Biotechnologies by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Adaptive Biotechnologies Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Adaptive Biotechnologies' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Adaptive Biotechnologies' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Adaptive Biotechnologies Market Strength Events
Market strength indicators help investors to evaluate how Adaptive Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Adaptive Biotechnologies shares will generate the highest return on investment. By undertsting and applying Adaptive Biotechnologies stock market strength indicators, traders can identify Adaptive Biotechnologies Corp entry and exit signals to maximize returns.
| Accumulation Distribution | 188832.0 | |||
| Daily Balance Of Power | 0.3 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 2.38 | |||
| Day Typical Price | 2.39 | |||
| Price Action Indicator | 0.05 | |||
| Period Momentum Indicator | 0.06 |
Adaptive Biotechnologies Risk Indicators
The analysis of Adaptive Biotechnologies' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Adaptive Biotechnologies' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting adaptive stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.02 | |||
| Standard Deviation | 5.09 | |||
| Variance | 25.89 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Adaptive Biotechnologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Adaptive Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adaptive Biotechnologies will appreciate offsetting losses from the drop in the long position's value.Moving together with Adaptive Stock
| 0.77 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.76 | ME | 23Andme Holding | PairCorr |
Moving against Adaptive Stock
| 0.87 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
| 0.72 | DOMH | Dominari Holdings | PairCorr |
| 0.58 | VCEL | Vericel Corp Ord Financial Report 8th of May 2024 | PairCorr |
| 0.57 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.52 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
The ability to find closely correlated positions to Adaptive Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Adaptive Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Adaptive Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Adaptive Biotechnologies Corp to buy it.
The correlation of Adaptive Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Adaptive Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Adaptive Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Adaptive Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Adaptive Biotechnologies to cross-verify your projections. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Adaptive Stock analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |
Is Adaptive Biotechnologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adaptive Biotechnologies. If investors know Adaptive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adaptive Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.56) | Revenue Per Share 1.179 | Quarterly Revenue Growth (0.17) | Return On Assets (0.17) | Return On Equity (0.58) |
The market value of Adaptive Biotechnologies is measured differently than its book value, which is the value of Adaptive that is recorded on the company's balance sheet. Investors also form their own opinion of Adaptive Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adaptive Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adaptive Biotechnologies' market value can be influenced by many factors that don't directly affect Adaptive Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adaptive Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adaptive Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adaptive Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.